Few data regarding the prevalence and prognostic impact of mitral regurgitation (MR) in patients with worsening chronic or new-onset acute heart failure (HF) are available. We investigated the role of MR in the BIOlogy Study to TAilored Treatment in Chronic Heart Failure (BIOSTAT-CHF)
AimsFew data are available regarding changes in mitral regurgitation (MR) severity with guideline-di...
International audienceBackground Few data are available regarding changes in mitral regurgitation (M...
Aims: Few data regarding the prevalence and prognostic impact of mitral regurgitation (MR) in patien...
BackgroundFew data regarding the prevalence and prognostic impact of mitral regurgitation (MR) in pa...
Aims Few data regarding the prevalence and prognostic impact of mitral regurgitation (MR) in patient...
International audienceAims: Few data regarding the prevalence and prognostic impact of mitral regurg...
AimsFew data are available regarding changes in mitral regurgitation (MR) severity with guideline-di...
International audienceBackground Few data are available regarding changes in mitral regurgitation (M...
Aims: Few data regarding the prevalence and prognostic impact of mitral regurgitation (MR) in patien...
BackgroundFew data regarding the prevalence and prognostic impact of mitral regurgitation (MR) in pa...
Aims Few data regarding the prevalence and prognostic impact of mitral regurgitation (MR) in patient...
International audienceAims: Few data regarding the prevalence and prognostic impact of mitral regurg...
AimsFew data are available regarding changes in mitral regurgitation (MR) severity with guideline-di...
International audienceBackground Few data are available regarding changes in mitral regurgitation (M...
Aims: Few data regarding the prevalence and prognostic impact of mitral regurgitation (MR) in patien...